Form 8-K - Current report:
SEC Accession No. 0001493152-24-008489
Filing Date
2024-03-01
Accepted
2024-03-01 16:05:20
Documents
20
Period of Report
2024-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59332
2 ex1-1.htm EX-1.1 547279
3 ex4-1.htm EX-4.1 119915
4 ex4-2.htm EX-4.2 75787
5 ex5-1.htm EX-5.1 15743
6 ex99-1.htm EX-99.1 10425
7 ex5-1_001.jpg GRAPHIC 21847
  Complete submission text file 0001493152-24-008489.txt   1192609

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ogen-20240227.xsd EX-101.SCH 3018
9 XBRL LABEL FILE ogen-20240227_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE ogen-20240227_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3630
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 24709568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)